Johnson & Johnson Coronavirus Vaccine Enters Late-Stage Trial Testing

Credit: Veuer

Duration: 01:10s 23 Sep 2020 0 shares 1 views

Johnson & Johnson Coronavirus Vaccine Enters Late-Stage Trial Testing

Johnson & Johnson's Covid-19 vaccine candidate begins Phase 3 trials.

Veuer’s Maria Mercedes Galuppo has the story.

Advertisement

Related news coverage

Pfizer's record breaking 9 month sprint to COVID-19 vaccine: A timeline

Mid-Day 21 Nov 2020

Pfizer announced Friday it is seeking emergency approval from US regulators for its Covid-19 vaccine, which has shown 95 percent..

NA Proactive news snapshot: Alpine 4 Technologies, HealthLynked, CytoDyn, Nemaura Medical UPDATE ...
Proactive Investors 17 Nov 2020
'In dialogue with all vaccine manufacturers,' government on Pfizer's successful trial
Mid-Day 11 Nov 2020
Which Covid vaccine candidates are competing against Pfizer?
Proactive Investors 10 Nov 2020
Who is competing against Pfizer COVID-19 vaccine candidate?
Proactive Investors 10 Nov 2020

You might like

More coverage

Covid Surge

Covid Surge

WTVQ Lexington, KY 14 Oct 2020

10142020_5am

Johnson & Johnson Begins Late-Stage Coronavirus Vaccine Trial

Johnson & Johnson Begins Late-Stage Coronavirus Vaccine Trial

Wochit Business

23 Sep 2020

Johnson & Johnson's Coronavirus Vaccine Enters Phase 3 Trial With Beth Israel

Johnson & Johnson's Coronavirus Vaccine Enters Phase 3 Trial With Beth Israel

WBZ CBS Boston

23 Sep 2020

Johnson & Johnson COVID Vaccine Enters Pivotal Stage

Johnson & Johnson COVID Vaccine Enters Pivotal Stage

CBS 2 New York

23 Sep 2020

Which Covid vaccine candidates are competing against Pfizer ?

Proactive Investors

10 Nov 2020